Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy and Dental Medicine, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Unit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Fez, Morocco.
Mol Biol Rep. 2024 Jan 28;51(1):233. doi: 10.1007/s11033-023-09200-y.
Dravet syndrome is a severe form of epilepsy characterised by recurrent seizures and cognitive impairment. It is mainly caused by variant in the SCN1A gene in 90% of cases, which codes for the α subunit of the voltage-gated sodium channel. In this study, we present one suspected case of Dravet syndrome in Moroccan child that underwent exome analysis and were confirmed by Sanger sequencing. The variant was identified in the SCN1A gene, and is a new variant that has never been described in the literature. The variant was found de nova in our case, indicating that it was not inherited from the parents. The variant, SCN1A c.965-2A>G p.(?), is located at the splice site and results in an unknown modification of the protein. This variant is considered pathogenic on the basis of previous studies. These results contribute to our knowledge of the SCN1A gene mutations associated with Dravet syndrome and underline the importance of genetic analysis in the diagnosis and confirmation of this disorder. Further studies are needed to better understand the functional consequences of this variant and its implications for therapeutic strategies in Dravet syndrome.
德拉维特综合征是一种严重的癫痫症,其特征是反复发作和认知障碍。它主要由 90%病例中的 SCN1A 基因突变引起,该基因编码电压门控钠离子通道的α亚基。在这项研究中,我们介绍了一例摩洛哥儿童疑似德拉维特综合征的病例,该病例接受了外显子组分析,并通过 Sanger 测序得到证实。该变体存在于 SCN1A 基因中,是一种从未在文献中描述过的新变体。该变体在我们的病例中为新发突变,表明它不是从父母那里遗传的。变体 SCN1A c.965-2A>G p.(?)位于剪接位点,导致蛋白的未知修饰。根据以往的研究,该变体被认为是致病性的。这些结果有助于我们了解与德拉维特综合征相关的 SCN1A 基因突变,并强调了遗传分析在该疾病的诊断和确认中的重要性。需要进一步的研究来更好地了解该变体的功能后果及其对德拉维特综合征治疗策略的影响。